Why is Amrutanjan Health Care Ltd ?
1
High Management Efficiency with a high ROE of 17.54%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 6.69% and Operating profit at -0.24% over the last 5 years
4
Flat results in Sep 26
5
Stock is technically in a Mildly Bearish range
- The technical trend has deteriorated from Sideways on 20-Nov-26
- The stocks MACD and KST technical factors are also Bearish
6
With ROE of 17.7, it has a Attractive valuation with a 4 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -27.02%, its profits have risen by 15.6% ; the PEG ratio of the company is 1.4
7
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -4.35% over the previous quarter and collectively hold 10.37% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you hold?
- Overall Portfolio exposure to Amrutanjan Healt should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Amrutanjan Healt for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Amrutanjan Healt
-27.02%
-0.91
29.70%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
6.69%
EBIT Growth (5y)
-0.24%
EBIT to Interest (avg)
54.07
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
1.45
Tax Ratio
25.15%
Dividend Payout Ratio
26.16%
Pledged Shares
0
Institutional Holding
10.37%
ROCE (avg)
33.76%
ROE (avg)
17.54%
Valuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
40
Price to Book Value
3.98
EV to EBIT
19.98
EV to EBITDA
17.84
EV to Capital Employed
4.31
EV to Sales
2.72
PEG Ratio
1.44
Dividend Yield
0.96%
ROCE (Latest)
17.87%
ROE (Latest)
17.70%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Movement
4What is working for the Company
PBT LESS OI(Q)
At Rs 20.08 cr has Grown at 34.67%
PAT(Q)
At Rs 17.28 cr has Grown at 23.8%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Amrutanjan Healt
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 20.08 cr has Grown at 34.67%
Year on Year (YoY)MOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 17.28 cr has Grown at 23.8%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)